Pages that link to "Q80270099"

The following pages link to Abeta40 protects non-toxic Abeta42 monomer from aggregation (Q80270099):

Displaying 44 items.

• The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway (Q24294387) (← links)
• Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio (Q24298670) (← links)
• Interaction between soluble Aβ-(1-40) monomer and Aβ-(1-42) fibrils probed by paramagnetic relaxation enhancement (Q24318268) (← links)
• Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis (Q24633896) (← links)
• Residual structure, backbone dynamics, and interactions within the synuclein family (Q24671058) (← links)
• Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease (Q26827421) (← links)
• Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue (Q27665898) (← links)
• A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling (Q31041418) (← links)
• Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. (Q34043216) (← links)
• A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor (Q34307478) (← links)
• Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly (Q34402886) (← links)
• Synergistic interactions between Alzheimer's Aβ40 and Aβ42 on the surface of primary neurons revealed by single molecule microscopy (Q35061472) (← links)
• Modes of Aβ toxicity in Alzheimer's disease (Q35235869) (← links)
• Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease (Q35774046) (← links)
• Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices? (Q36022784) (← links)
• Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures (Q36827322) (← links)
• Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils (Q37028176) (← links)
• Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies (Q37057927) (← links)
• An update on the toxicity of Abeta in Alzheimer's disease (Q37106932) (← links)
• E22Q-mutant Abeta peptide (AbetaDutch) increases vascular but reduces parenchymal Abeta deposition (Q37150728) (← links)
• Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation (Q37157432) (← links)
• Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors (Q37174236) (← links)
• Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach (Q37191689) (← links)
• Animal models of Alzheimer's disease and frontotemporal dementia (Q37196122) (← links)
• Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization (Q37230015) (← links)
• Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42. (Q37364324) (← links)
• Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery (Q37381344) (← links)
• Development and mechanism of γ-secretase modulators for Alzheimer's disease (Q38101383) (← links)
• Interpreting Alzheimer's disease clinical trials in light of the effects on amyloid-β. (Q38230384) (← links)
• Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease (Q38589816) (← links)
• The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity (Q39101514) (← links)
• Amyloid precursor protein and tau transgenic models of Alzheimer‘s disease: insights from the past and directions for the future (Q39420600) (← links)
• γ-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Aβ(42) /Aβ(40) ratio (Q39545955) (← links)
• The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity (Q39951771) (← links)
• Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity (Q39982408) (← links)
• C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. (Q40785358) (← links)
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide (Q42040291) (← links)
• Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease (Q44369500) (← links)
• Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome. (Q46830566) (← links)
• The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. (Q47110086) (← links)
• Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage (Q47665801) (← links)
• Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease (Q48742654) (← links)
• Amyloid β-peptides 1-40 and 1-42 form oligomers with mixed β-sheets. (Q54959267) (← links)
• γ-Secretase and its modulators: Twenty years and beyond (Q91581374) (← links)